Psychiatry and Neurology, Neurology · Amarillo, TX
NPI
1861438061
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
6700 W 9th Ave
Amarillo, TX, 79106
Phone (806) 358-0200
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.2M
107,312 services
Medicare patients, 2024
1,118
Average age 72
Drug cost, 2024
$4.4M
4,744 prescriptions
Company payments, 2025
$67K
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sean M Milligan was code J2323 (injection, natalizumab, 1 mg), 45,600 times for 17 patients. In total Sean M Milligan billed 107,312 services in 84 codes, and Medicare paid $2.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2323 Injection, natalizumab, 1 mg | Office | 45,600 | 17 | $18.39 | $839K |
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 35,800 | 49 | $4.94 | $177K |
| 99214 Office E&M - Established | Office | 895 | 576 | $87.03 | $78K |
| 99213 Office E&M - Established | Office | 437 | 360 | $59.01 | $26K |
| 96365 Intravenous Infusion, Hydration | Office | 275 | 44 | $42.17 | $12K |
| 36415 Venipuncture Blood Collection | Office | 204 | 192 | $8.61 | $1,756 |
| 99204 Office E&M - New | Office | 181 | 181 | $111.39 | $20K |
| 95886 Electrical Nerve Conductivity | Office | 162 | 101 | $67.82 | $11K |
| 99215 Office E&M - Established | Office | 147 | 110 | $130.81 | $19K |
| 64615 Musculoskeletal | Office | 129 | 41 | $106.82 | $14K |
| 82607 Clinical Chemistry | Office | 93 | 93 | $14.78 | $1,375 |
| 96415 Chemotherapy Administration | Office | 71 | 12 | $20.69 | $1,469 |
| 82746 Clinical Chemistry | Office | 70 | 70 | $14.41 | $1,009 |
| 95970 Electrical Nerve Conductivity | Office | 61 | 26 | $13.14 | $802 |
| 96375 Injection Administration | Office | 56 | 14 | $11.47 | $642 |
By year: 2022 $2.0M for 73,517 services; 2023 $2.5M for 102,644 services; 2024 $2.2M for 107,312 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 204 | 192 | $8.61 | $1,756 |
| 82607 Clinical Chemistry | 93 | 93 | $14.78 | $1,375 |
| 82746 Clinical Chemistry | 70 | 70 | $14.41 | $1,009 |
| 85025 Blood Count | 49 | 39 | $7.48 | $367 |
| 80076 Clinical Chemistry | 25 | 18 | $7.73 | $193 |
| 80053 Clinical Chemistry | 21 | 20 | $10.35 | $217 |
| 84443 Clinical Chemistry | 18 | 18 | $16.46 | $296 |
| 82306 Clinical Chemistry | 12 | 12 | $29.01 | $348 |
| 84439 Clinical Chemistry | 11 | 11 | $8.84 | $97.24 |
Medicare prescription drug claims, 2024
In 2024, the drug Sean M Milligan prescribed most often to Medicare patients was Memantine Hcl, with 331 prescriptions and refills. In total Sean M Milligan wrote 4,744 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Memantine Hcl Generic | 331 | 724 | 92 | $8,682 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 254 | 394 | 61 | $5,704 |
| Lamotrigine Generic | 188 | 388 | 43 | $3,622 |
| Levetiracetam Generic | 182 | 364 | 43 | $6,994 |
| Duloxetine Hcl Generic | 167 | 314 | 30 | $3,627 |
| Topiramate Generic | 151 | 301 | 31 | $2,346 |
| Clonazepam Generic | 150 | 178 | 31 | $1,055 |
| Gabapentin Generic | 140 | 204 | 26 | $3,108 |
| Propranolol Hcl Er Propranolol Hcl | 124 | 235 | 27 | $3,537 |
| Rytary Carbidopa/Levodopa | 115 | 181 | 24 | $108K |
| Donepezil Hcl Generic | 100 | 196 | 28 | $1,327 |
| Tizanidine Hcl Generic | 90 | 131 | 14 | $838 |
| Briviact Brivaracetam | 78 | 84 | 12 | $114K |
| Carbamazepine Er Carbamazepine | 74 | 145 | 19 | $13K |
| Baclofen Generic | 69 | 87 | 14 | $1,720 |
Brand drugs: 1,005 claims; generic drugs: 3,714 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sean M Milligan $67K ($67K in general payments such as food, travel and fees) from 28 companies. The largest payer was Alexion Pharmaceuticals, Inc. with $21K.
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. AZN | 33 | $21K |
| Amgen Inc. AMGN | 24 | $20K |
| Abbvie Inc. ABBV | 32 | $13K |
| Biogen, Inc. BIIB | 20 | $11K |
| Pfizer Inc. PFE | 19 | $250 |
| EMD Serono, Inc. MRK.DE | 12 | $205 |
| UCB, Inc. UCB.BR | 9 | $174 |
| Genentech USA, Inc. ROG.SW | 5 | $89.46 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $74.4 |
| Neurocrine BioSciences, Inc. NBIX | 3 | $71.82 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.